Canaccord Genuity Maintains Salesforce (CRM) Buy Recommendation

(Source: Nasdaq) Fintel reports that on May 30, 2023, Canaccord Genuity maintained coverage of Salesforce (NYSE:CRM) with a Buy recommendation.